-
Han JY
, Park K, Kim SW, Lee DH, et al.
First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin
trial in never-smokers with adenocarcinoma of the lung. J Clin Oncol 2012;30:1122-8.
-
Lu E
, Wang BW, Guimond C, Synnes A, et al.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review. Neurology 2012.
-
Saver JL
, Jahan R, Levy EI, Jovin TG, et al.
Solitaire flow restoration device versus the Merci Retriever in patients with
acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority
trial. Lancet 2012.
-
Mowry EM
, Waubant E, McCulloch CE, Okuda DT, et al.
Vitamin D status predicts new brain magnetic resonance imaging activity in
multiple sclerosis. Ann Neurol 2012;72:234-40.
-
Jim HS
, Phillips KM, Chait S, Faul LA, et al.
Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously
Treated With Standard-Dose Chemotherapy. J Clin Oncol 2012.
|